CAMPBELL BRADLEY L (President and CEO) reported 1 transaction at AMICUS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/30/2025ACC: 0001193125-25-337338
DirectorOfficer· President and CEO
Since Mar 2026
-108.60K
Net shares
Net seller
$1.55M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
108.60K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−108.60K
Price / share
$14.25
Trade value
$1.55M
% of position
9.6%
12/26/2025
1.13M→1.02M
Total
Net shares
−108.60K
Net value
-$1.55M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/26/2025 | F · Tax Withholding | −108.60K | $14.25 | $1.55M | 9.6% | 1.13M | 1.02M |
| Total | −108.60K | -$1.55M | ||||||
Derivative Transactions0
No derivative transactions reported